Vanda falls 21% as tradipitant fails in phase 3 study for gastroparesis
February 04 2022 - 08:30AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Mar 2023 to Mar 2024